DT-diaphorase and cytochrome B5 reductase in human lung and breast tumours

British Journal of Cancer

Volumn 76, Issue 7, 1997, Pages 923-929

  Marin A ^a   Lopez De Cerain A ^a   Hamilton, E ^b   Lewis, A D ^c   Martinez Penuela J M ^d   Idoate, M A ^a   Bello, J ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b ASTRAZENECA   (United Kingdom)

^c HERIOT WATT UNIVERSITY   (United Kingdom)

^d Universidad Pública de Navarra   (Spain)

Author keywords

Bioreductive drugs; Breast tumours; Cytochrome b5 reductase; DT diaphorase; Human non small cell lung tumours; Western blot

Indexed keywords

CYTOCHROME B5 REDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ADULT; AGED; ARTICLE; BREAST TUMOR; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE LEVEL;

EID: 0030768982     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.485     Document Type: Article

References (38)

1. American Joint Committee on Cancer (AJCC) (1992) Manual for Staging of Cancer, 4th edn. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ (eds). J.B. Lippincott Company: Philadelphia
2. Belinsky M and Jaiswal AK (1993) NAD(P)H: quinone oxidoreductase (DT-diaphorase) expression in normal and tumor tissues. Cancer Metast Rev 12: 103-117
3. Chesis PL, Levin DE, Smith MT, Ernster L and Ames BN (1984) Mutagenicity of quinones: pathways of metabolic activation and detoxification. Proc Natl Acad Sci USA 81: 1696-1700
4. Cresteil T and Jaiswal AK (1991) High levels of expression of the NAD(P)H: quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same origin. Biochem Pharmacol 42: 1021-1027
5. Doherty N, Hancock SL, Kaye S, Coleman CN, Shulman L, Marquez C, Mariscal C, Rampling R, Senan S and Roemeling RV (1994) Muscle cramping in phase I clinical trials of tirapazamine (SR4233) with and without radiation. Int J Radiat Oncol Biol Phys 29: 379-382
6. Edwards Y, Potter J and Hopkinson DA (1980) Human FAD-dependent NAD(P)H diaphorase. Biochem J 187: 429-436
7. Ernster L (1967) DT-diaphorase. Methods Enzymol 10: 309-317
8. Fitzsimmons SA, Workman P, Grever M, Kenneth P, Camalier R and Lewis AD (1996) Reductase enzyme expression across the National Cancer Institute Tumor Cell Line Panel: correlation with sensitivity to mitomycin C and E09. J Natl Cancer Inst 88: 259-269
9. 5R reductase. Cancer Res 53: 4907-4912
10. Iyanagi T and Yamazaki I (1969) One-electron-transfer reactions in biochemical systems. III. One-electron reduction of quinones by microsomal flavin enzymes. Biochim Biophys Acta 172: 370-381
11. Jaiswal A, Burnett P, Adesnik M and McBride OW (1990) Nucleotide and deduced aminoacid sequence of human cDNA (NQO2) corresponding to a second member of the polymorphism at the NQO2 gene locus on chromosome 6. Biochemistry 29: 1899-1906
12. Kennedy KA, Teicher BA, Rockwell S and Sartorelli AC (1980) The hypoxic tumor cell: a target for selective cancer chemotherapy. Biochem Pharmacol 29: 1-8
13. Laemmli U-K (1970) Cleavage of structural proteins during the assembly of head of bacteriophage T4. Nature 227: 680-685
14. Lewis AD, Holyoake TL, Dunlop DJ, Pragnell I and Workman P (1993) Lack of myelosuppression with low DT-diaphorase. Proc Am Assoc Cancer Res 34: A2057
15. Lind C (1985) Relationship between the role of reduction of benzo(a)pyrene-3,6-quinone and the formation of benzo(a)pyrene-3,6-quinol glucuronides in rat liver microsomes. Biochem Pharmacol 34: 895-897
16. Nohl H, Jordan W and Youngman RJ (1986) Quinones in biology, functions in electron transfer and oxygen activation. Adv Free Rad Biol Med 2: 211-279
17. Plumb JA, Gerritsen M and Workman P (1994a) DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone E09. Br J Cancer 70: 1136-1143
18. Plumb JA, Gerritsen M, Milroy R, Thomson P and Workman P (1994b) Relative importance of DT-diaphorase and hypovia in the bioactivation of E09 by human lung tumour cells lines. Int J Radiat Oncol Biol Phys 29: 295-299
19. Prochaska HJ and Talalay P (1988) Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine livers. Cancer Res 48: 4776-4782
20. Prochaska HJ, Talalay P and Sies H (1987) Direct protective effect of NAD(P)H: quinone reductase against menadione-induced chemiluminescence of postmitochondrial fractions of mouse liver. J Biol Chem 262: 1931-1934
21. Riley RJ and Workman P (1992) DT-diaphorase and cancer chemotherapy. Biochem Pharmacol 43: 1657-1659
22. Robertson N, Haigh A, Adams GE and Stratford IJ (1994) Factors affecting the sensitivity of E09 in rodent and human tumour cells in vitro: DT-diaphorase and hypoxia. Eur J Cancer 30A: 1013-1019
23. Robinson C and Castañer J (1995) Tirapazamine. Bioreductive hypoxic cell cytotoxin. Drugs of the Future 20: 256-263
24. Sartorelli AC (1988) Therapeutic attack of hypoxic cells of solid tumors: presidential address. Cancer Res 48: 775-778
25. Schellens JH, Planting AS, Van Acker BA, Loos WJ, De Boer Dennert M, Van Der Burg ME, Koier I, Krediet RT, Stoter G and Verwey J (1994) Phase 1 and pharmacologic study of the novel indoloquinone bioreductive alkylating cytotoxic drug E09. J Natl Cancer Inst 86: 906-12
26. Schlager JJ and Powis G (1990) Cytosolic NAD(P)H: (quinone acceptor) oxidoreductase in human normal and tumor tissue: effects of cigarette smoking and alcohol. Int J Cancer 45: 403-409
27. Schor NA and Cornelisse CJ (1983) Biochemical and quantitative histochemical study of reduced pyridine nucleotide dehydrogenation by human colon carcinomas. Cancer Res 43: 4850-4855
28. Segura-Aguilar JE and Lind C (1987) Isolation and characterization of DT-diaphorase enzymes from rat liver. Chem Scripta 27A: 37-41
29. Sies H (1986) Biochemistry of oxidative stress. Angew Chem Int Ed Eng 25: 1058-1071
30. Smith PK, Krohn IR, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ and Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85
31. Smitskamp-Wilms E, Giaccone G, Pinedo HM, Van Der Laan BFAM and Peters GJ (1995) DT-diaphorase activity in normal and neoplastic human tissues: an indicator for sensitivity to bioreductive agents? Br J Cancer 72: 917-921
32. Suttle JN (1985) Vitamin K-dependent carboxylase. Annu Rev Biochem 54: 459-477
33. Tomasz M, Lipman R, Chowdary D, Pawlek J, Verdine GL and Nakanishi K (1987) Isolation and structure of covalent cross-link adduct between mitomycin C and DNA. Science 235: 1204-1208
34. Wermuth B (1981) Purification and properties of an NADPH-dependent carbonyl reductase from human brain. Relationship to prostaglandin 9-ketoreductase and xenobiotic ketone reductase. J Biol Chem 256: 1206-1213
35. Workman P (1992) Keynote address: bioreductive mechanisms. Int J Radiat Oncol Biol Phys 22: 631-637
36. Workman P (1994) Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolising enzymes, particularly DT-diaphorase. Oncol Res 6: 461-475
37. Workman P and Stratford IJ (1993) The experimental development of bioreductive drugs and their role in cancer therapy. Cancer Metast Rev 12:73-82
38. Workman P and Walton MI (1990) Enzyme-directed bioreductive drug development. In Selective Activation of Drugs by Redox Processes, Adams GE, Breccia A, Fielden EM and Wardman P (eds), pp. 173-191. Plenum Press: New York